Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-398-6 | CAS number: 106-44-5
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: in vitro investigation
Data source
Reference
- Reference Type:
- publication
- Title:
- Permeability of human epidermis to the phenolic compounds
- Author:
- Roberts MS, Anderson RA, Swarbrick J
- Year:
- 1 977
- Bibliographic source:
- J. Pharm. Pharmac. 29, 677-683
Materials and methods
- Principles of method if other than guideline:
- The permeability of p-cresol was measured across epidermal membranes from human abdominal skin in vitro.
- GLP compliance:
- no
Test material
- Reference substance name:
- p-cresol
- EC Number:
- 203-398-6
- EC Name:
- p-cresol
- Cas Number:
- 106-44-5
- Molecular formula:
- C7H8O
- IUPAC Name:
- p-cresol
- Details on test material:
- IUCLID4 Test substance: other TS: p-cresol, purity: reagent grade
Constituent 1
- Radiolabelling:
- not specified
Test animals
- Species:
- human
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- see section: any other information on material and method"
Administration / exposure
- Type of coverage:
- other: in vitro
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 250 minutes
- Doses:
- see section" additional information on materials and methods"
- No. of animals per group:
- in vitro study
- Details on study design:
- see section "any other information on materials and methods"
- Details on in vitro test system (if applicable):
- see section "any other information on materials and methods"
Results and discussion
- Signs and symptoms of toxicity:
- not specified
- Remarks:
- in vitro examination
- Dermal irritation:
- not specified
- Remarks:
- in vitro examination
- Absorption in different matrices:
- see section "executive summary"
- Total recovery:
- see section "executive summary"
Percutaneous absorption
- Dose:
- see section "executive summary"
- Remarks on result:
- other: see section "executive summary"
- Remarks:
- in vitro test: see section "executive summary"
- Conversion factor human vs. animal skin:
- no data
Any other information on results incl. tables
see section "executive summary"
Applicant's summary and conclusion
- Executive summary:
The permeability efficient of p-cresol (in vitro human abdominal skin) was 2.92 x 10[exp-4] cm/min and the lag time for a 0.4 %w/v solution was 16 min. The threshold concentration for damage i.e. the aquous concentration at which the permeability coefficient began to increase was 8.85 %w/v.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
